NEOGENOMICS INC
NEONASDAQ🏆 #1806 by market capEarnings Feb 15 · PostUS Equity
$17.92▼ $0.08 (−0.44%)
🌙 After hours$17.93▲ 0.06%Regular close · extended-hours price shownTrack NEO
Get earnings, price moves & breaking news on Telegram
24h▼ 0.4%
7d▲ 8.1%
14d▲ 7.6%
30d▼ 2.4%
ytd▲ 52.5%
1y▲ 84.9%
🏦Market Cap
$2.30B
Small Cap
📈Revenue Growth (YoY)
11.2%
Healthy
📊Gross Margin
43.9%
Healthy
💵FCF Margin
1.6%
Thin
⚖️P/S Ratio
3.0x
Fair
Otter Score
60
Fair
NEOGENOMICS INC
NEOAnalyst Ratings
Price
$17.92
Total
30
Raised
4
Lowered
4
Avg PT
$22.50
H / L
$28 / $19
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
TD Cowen | Reiterated | Buy | 2026-10-29 | — | — |
BTIG | Reiterated | Buy | 2026-10-29 | $28.00 | +56.20% |
Needham | Reiterated | Buy | 2026-10-06 | $22.00 | +22.80% |
StoneX | Reiterated | Buy | 2026-10-06 | — | — |
Benchmark | Reiterated | Buy | 2026-07-24 | — | — |
Leerink Partners | Upgraded | Market Perform → Outperform | 2026-04-29 | $25.00 | +39.50% |
Piper Sandler | Reiterated | Overweight | 2026-02-24 | $13.00 | −27.50% |
Stephens & Co. | Reiterated | Overweight | 2025-09-02 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2025-07-30 | $8.00 | −55.40% |
William Blair | Downgraded | Outperform → Market Perform | 2025-07-29 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-04-30 | $20.00 | +11.60% |
B of A Securities | Reiterated | Neutral | 2025-02-19 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2023-05-16 | $15.00 | −16.30% |
Cowen & Co. | Reiterated | Outperform | 2023-02-24 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-11-09 | — | — |
Truist Securities | Reiterated | Buy | 2021-01-28 | — | — |
Guggenheim | Reiterated | Buy | 2020-08-28 | $54.00 | +201.30% |
Craig-Hallum | Reiterated | Buy | 2020-03-02 | $19.00 | +6.00% |
First Analysis | Upgraded | Outperform → Strong Buy | 2020-02-28 | — | — |
CIBC | Upgraded | Neutral → Outperform | 2019-03-12 | — | — |
Leerink Swann | Reiterated | Outperform | 2018-08-21 | — | — |
BTIG Research | Upgraded | Neutral → Outperform | 2018-04-16 | — | — |
Gabelli & Co. | Reiterated | Buy | 2017-08-24 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2016-12-15 | — | — |
Axiom Capital | Downgraded | Hold → Sell | 2016-11-16 | — | — |
Janney Capital | Reiterated | Buy | 2016-01-08 | — | — |
Longbow Research | Reiterated | Buy | 2014-05-12 | — | — |
Roth Capital | Reiterated | Buy | 2014-05-12 | — | — |
Sidoti & Co. | Reiterated | Buy | 2013-05-01 | — | — |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2013-04-25 | — | — |
Institution
TD Cowen
Reiterated · Buy · 2026-10-29
—
—
BTIG
Reiterated · Buy · 2026-10-29
$28.00
+56.20%
Needham
Reiterated · Buy · 2026-10-06
$22.00
+22.80%
StoneX
Reiterated · Buy · 2026-10-06
—
—
Benchmark
Reiterated · Buy · 2026-07-24
—
—
Leerink Partners
Upgraded · Market Perform → Outperform · 2026-04-29
$25.00
+39.50%
Piper Sandler
Reiterated · Overweight · 2026-02-24
$13.00
−27.50%
Stephens & Co.
Reiterated · Overweight · 2025-09-02
—
—
Morgan Stanley
Reiterated · Equal Weight · 2025-07-30
$8.00
−55.40%
William Blair
Downgraded · Outperform → Market Perform · 2025-07-29
—
—
Goldman Sachs
Reiterated · Buy · 2025-04-30
$20.00
+11.60%
B of A Securities
Reiterated · Neutral · 2025-02-19
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2023-05-16
$15.00
−16.30%
Cowen & Co.
Reiterated · Outperform · 2023-02-24
—
—
SVB Leerink
Reiterated · Outperform · 2022-11-09
—
—
Truist Securities
Reiterated · Buy · 2021-01-28
—
—
Guggenheim
Reiterated · Buy · 2020-08-28
$54.00
+201.30%
Craig-Hallum
Reiterated · Buy · 2020-03-02
$19.00
+6.00%
First Analysis
Upgraded · Outperform → Strong Buy · 2020-02-28
—
—
CIBC
Upgraded · Neutral → Outperform · 2019-03-12
—
—
Leerink Swann
Reiterated · Outperform · 2018-08-21
—
—
BTIG Research
Upgraded · Neutral → Outperform · 2018-04-16
—
—
Gabelli & Co.
Reiterated · Buy · 2017-08-24
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2016-12-15
—
—
Axiom Capital
Downgraded · Hold → Sell · 2016-11-16
—
—
Janney Capital
Reiterated · Buy · 2016-01-08
—
—
Longbow Research
Reiterated · Buy · 2014-05-12
—
—
Roth Capital
Reiterated · Buy · 2014-05-12
—
—
Sidoti & Co.
Reiterated · Buy · 2013-05-01
—
—
Ladenburg Thalmann
Downgraded · Buy → Neutral · 2013-04-25
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space